136 related articles for article (PubMed ID: 21197415)
1. Development of a serum biomarker assay that differentiates tumor-associated MUC5AC (NPC-1C ANTIGEN) from normal MUC5AC.
Luka J; Arlen PM; Bristol A
J Biomed Biotechnol; 2011; 2011():934757. PubMed ID: 21197415
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
Patel SP; Bristol A; Saric O; Wang XP; Dubeykovskiy A; Arlen PM; Morse MA
Cancer Immunol Immunother; 2013 Jun; 62(6):1011-9. PubMed ID: 23591984
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer.
Zhang J; Wang Y; Zhao T; Li Y; Tian L; Zhao J; Zhang J
World J Surg Oncol; 2020 Feb; 18(1):31. PubMed ID: 32028958
[TBL] [Abstract][Full Text] [Related]
4. Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer.
Liu D; Chang CH; Gold DV; Goldenberg DM
Oncotarget; 2015 Feb; 6(6):4274-85. PubMed ID: 25595893
[TBL] [Abstract][Full Text] [Related]
5. Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin.
Gold DV; Newsome G; Liu D; Goldenberg DM
Mol Cancer; 2013 Nov; 12(1):143. PubMed ID: 24257318
[TBL] [Abstract][Full Text] [Related]
6. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.
Kaur S; Smith LM; Patel A; Menning M; Watley DC; Malik SS; Krishn SR; Mallya K; Aithal A; Sasson AR; Johansson SL; Jain M; Singh S; Guha S; Are C; Raimondo M; Hollingsworth MA; Brand RE; Batra SK
Am J Gastroenterol; 2017 Jan; 112(1):172-183. PubMed ID: 27845339
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma.
Manne A; Esnakula A; Abushahin L; Tsung A
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205412
[TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer.
Yamazoe S; Tanaka H; Iwauchi T; Yoshii M; Ito G; Amano R; Yamada N; Sawada T; Ohira M; Hirakawa K
Pancreas; 2011 Aug; 40(6):896-904. PubMed ID: 21697763
[TBL] [Abstract][Full Text] [Related]
9. Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis.
Xu Y; Zhang L; Hu G
Biologicals; 2009 Jan; 37(1):18-25. PubMed ID: 18848467
[TBL] [Abstract][Full Text] [Related]
10. Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro.
Chorley BN; Crews AL; Li Y; Adler KB; Minnicozzi M; Martin LD
Respir Res; 2006 Feb; 7(1):35. PubMed ID: 16504136
[TBL] [Abstract][Full Text] [Related]
11. Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.
Yue T; Maupin KA; Fallon B; Li L; Partyka K; Anderson MA; Brenner DE; Kaul K; Zeh H; Moser AJ; Simeone DM; Feng Z; Brand RE; Haab BB
PLoS One; 2011; 6(12):e29180. PubMed ID: 22220206
[TBL] [Abstract][Full Text] [Related]
12. Expression and Serum Levels of Mucin 5AC (MUC5AC) as a Biomarker for Cholangiocarcinoma: a Meta-analysis.
Pabalan N; Sukcharoensin S; Butthongkomvong K; Jarjanazi H; Thitapakorn V
J Gastrointest Cancer; 2019 Mar; 50(1):54-61. PubMed ID: 29139058
[TBL] [Abstract][Full Text] [Related]
13. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma.
Kocer B; McKolanis J; Soran A
BMC Gastroenterol; 2006 Jan; 6():4. PubMed ID: 16409634
[TBL] [Abstract][Full Text] [Related]
15. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody.
Reis CA; David L; Nielsen PA; Clausen H; Mirgorodskaya K; Roepstorff P; Sobrinho-Simões M
Int J Cancer; 1997 Feb; 74(1):112-21. PubMed ID: 9036879
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
[TBL] [Abstract][Full Text] [Related]
18. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer.
Henry KE; Shaffer TM; Mack KN; Ring J; Ogirala A; Klein-Scory S; Eilert-Micus C; Schmiegel W; Bracht T; Sitek B; Clyne M; Reid CJ; Sipos B; Lewis JS; Kalthoff H; Grimm J
J Nucl Med; 2021 Oct; 62(10):1384-1390. PubMed ID: 33712530
[TBL] [Abstract][Full Text] [Related]
19. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma.
Wongkham S; Sheehan JK; Boonla C; Patrakitkomjorn S; Howard M; Kirkham S; Sripa B; Wongkham C; Bhudhisawasdi V
Cancer Lett; 2003 May; 195(1):93-9. PubMed ID: 12767517
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Yamada D; Fujii K; Ishikawa N; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Int J Cancer; 2006 Jan; 118(2):405-11. PubMed ID: 16052519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
